Shuklendu Karyakarte, Ph.D.
Karyakarte received his doctorate in organic chemistry from the State University of New York at Buffalo. Under the supervision of Professor Sherry Chemler, his doctoral research focused on developing efficient routes towards the stereoselective syntheses of structurally diverse saturated oxygen and nitrogen heterocycles using copper (II)-mediated difunctionalizations of unactivated alkenes. After completing his Ph.D. studies, Karyakarte joined Boehringer Ingelheim Pharma Inc. (BI) in Ridgefield, Connecticut, as a post-doctoral intern. Under the supervision of Dr. Chris Senanayake and his team at BI, Shuklendu worked on the rational design and synthesis of novel ligands and their applications in diverse and useful organic transformations. He joined Southern Research in August 2017 as a postdoctoral fellow and is currently working in the area of antiviral drug discovery in the Antiviral Drug Discovery and Development Center (AD3C), one of the Centers of Excellence for Translation Research (CETR), funded through NIAID, NIH. He is responsible for providing synthetic chemistry efforts of various target compounds as potential therapeutics for the treatment of Chikungunya virus (CHIKV) and Venezuelan equine encephalitis virus (VEEV).